Home 2023

Ligand Pharmaceuticals

BPI News: Primrose Bio Blossoms from Pelican and Primordial Genetics Merger
Bioprocessing

BPI News: Primrose Bio Blossoms from Pelican and Primordial Genetics Merger

Jonathan D Grinstein, PhD -
0
Influenza and Coronavirus Demise Could Lie with Phage Nanoparticles
Coronavirus

Influenza and Coronavirus Demise Could Lie with Phage Nanoparticles

Jeffrey S. Buguliskis, Ph.D. -
0
The OmniAb<sup>®</sup> Platform: Human Sequence Antibodies from Mouse, Rat and Chicken® Platform: Human Sequence Antibodies from Mouse, Rat and Chicken />
OMICs

The OmniAb® Platform: Human Sequence Antibodies from Mouse, Rat and Chicken

Kathy Vuksanaj -
0
Advertorial: Gene Engineered Rats and Mice for Mono- and Bi-Specific Human Ab Generation
Sponsored

Advertorial: Gene Engineered Rats and Mice for Mono- and Bi-Specific Human Ab Generation

GEN Staff Writer -
0
Advertorial: OmniAb
Sponsored

Advertorial: OmniAb

GEN Staff Writer -
0
Ligand Licenses Four Programs to Seelos Therapeutics
Drug Discovery

Ligand Licenses Four Programs to Seelos Therapeutics

GEN Staff Writer -
0
Ligand to Acquire OMT for $178 Million
Drug Discovery

Ligand to Acquire OMT for $178 Million

GEN Staff Writer -
0
Ligand Buys Another 15 Biologics Programs from Selexis for $4M
Bioprocessing

Ligand Buys Another 15 Biologics Programs from Selexis for $4M

GEN Staff Writer -
0
Ligand Adds “Shots-on-Goal” with Avion Pharma Collaboration
News

Ligand Adds “Shots-on-Goal” with Avion Pharma Collaboration

GEN Staff Writer -
0
Ligand Licenses Lipid Technology to Omthera in Up to $44.5M Deal
News

Ligand Licenses Lipid Technology to Omthera in Up to $44.5M Deal

GEN Staff Writer -
0
1234Page 1 of 4
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.